Alemtuzumab, an IV treatment for relapsing-remitting MS, will head into expedited FDA review as soon as the current Phase III trial is completed. Learn more
For details on the therapeutic effects and adverse side effects of this treatment, see Dr. Loren Rolak’s report in our June 30 webcast, “What’s new in MS research and treatment.” Dr. Rolak’s presentation begins four-and-a-half minutes into the program. View webcast
Changes in access to health insurance and new health insurance rules are starting now with more to come this fall and next January. What does this mean to you? Our Health Care Reform team has created concise answers to the FAQs of people affected by MS.
From now to mid-September, see pivotal research papers FREE through a partnership among Fast Forward, the Society and Nature Publishing Group. Download papers on current work in stem cell transplantation, MS risk factors, neuroprotection and repair, and more.
Three noted MS investigators answered what, why, and when questions about new oral and infrequent dosing MS therapies, nervous system protection and repair, and the status of and new projects focused on CCSVI research.
This communication is partially sponsored through the generous support of Bayer HealthCare and Teva Pharmaceuticals, Inc.
June 11: Over $2.4 million committed to CCSVI research projects May 25: Fast Forward and Five Prime Therapeutics collaborate on new molecule that may benefit progressive as well as relapsing MS Read more about these and other recent reports
MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS. JOIN THE MOVEMENT®
Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please visit our Web site.
Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.
National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017
This message was sent to . To ensure that you continue to receive our emails, please add us to your address book.